版本:
中国

BRIEF-Agile Therapeutics says it plans to resubmit its NDA for Twirla in 1H 2017

March 16 Agile Therapeutics Inc

* Agile Therapeutics announces a poster presentation of its secure phase 3 study at the contraceptive technology 2017 conference

* Agile Therapeutics Inc- plans to resubmit its new drug application for Twirla in first half of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐